178 related articles for article (PubMed ID: 26971375)
1. Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system.
Ismaiel AA; Espinosa-Oliva AM; Santiago M; García-Quintanilla A; Oliva-Martín MJ; Herrera AJ; Venero JL; de Pablos RM
Toxicol Appl Pharmacol; 2016 May; 298():19-30. PubMed ID: 26971375
[TBL] [Abstract][Full Text] [Related]
2. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
3. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation.
Chung YC; Bok E; Huh SH; Park JY; Yoon SH; Kim SR; Kim YS; Maeng S; Park SH; Jin BK
J Immunol; 2011 Dec; 187(12):6508-17. PubMed ID: 22079984
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
Kim S; Moon M; Park S
J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
[TBL] [Abstract][Full Text] [Related]
7. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation.
Hwang CJ; Lee HP; Choi DY; Jeong HS; Kim TH; Lee TH; Kim YM; Moon DB; Park SS; Kim SY; Oh KW; Hwang DY; Han SB; Lee HJ; Hong JT
Oncotarget; 2016 Jul; 7(30):46943-46958. PubMed ID: 27409674
[TBL] [Abstract][Full Text] [Related]
11. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
12. Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice.
Wang Q; Shin EJ; Nguyen XK; Li Q; Bach JH; Bing G; Kim WK; Kim HC; Hong JS
J Neuroinflammation; 2012 Jun; 9():124. PubMed ID: 22695044
[TBL] [Abstract][Full Text] [Related]
13. Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model.
Kim MJ; Park M; Kim DW; Shin MJ; Son O; Jo HS; Yeo HJ; Cho SB; Park JH; Lee CH; Kim DS; Kwon OS; Kim J; Han KH; Park J; Eum WS; Choi SY
Biomaterials; 2015 Sep; 64():45-56. PubMed ID: 26117230
[TBL] [Abstract][Full Text] [Related]
14. M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models.
Youdim MB
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S151-4. PubMed ID: 22166418
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson's disease model.
Lee Y; Cho JH; Lee S; Lee W; Chang SC; Chung HY; Moon HR; Lee J
Brain Res; 2019 Feb; 1704():47-58. PubMed ID: 30273550
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
18. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
19. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
20. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
